TrialArthritis & rheumatology (Hoboken, N.J.)2015

Safety and efficacy of atacicept in combination with rituximab for reducing the signs and symptoms of rheumatoid arthritis: a phase II, randomized, double-blind, placebo-controlled pilot trial.

R F van Vollenhoven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.